Baxter International Stock Forecast, Price & News

16 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last twelve months. There are currently 6 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Baxter International stock.
View analyst ratings for Baxter International or view top-rated stocks.

Wall Street analysts have given Baxter International a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Baxter International wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Baxter International is scheduled to release its next quarterly earnings announcement on Thursday, April 29th 2021.
View our earnings forecast for Baxter International.

Baxter International Inc. (NYSE:BAX) announced its quarterly earnings data on Wednesday, February, 3rd. The medical instruments supplier reported $0.80 earnings per share for the quarter, topping the consensus estimate of $0.76 by $0.04. The medical instruments supplier had revenue of $3.18 billion for the quarter, compared to the consensus estimate of $3.10 billion. Baxter International had a net margin of 7.90% and a trailing twelve-month return on equity of 20.81%. The firm's revenue was up 4.7% compared to the same quarter last year. During the same quarter last year, the company earned $0.97 EPS.
View Baxter International's earnings history.

Baxter International's stock was trading at $77.97 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, BAX stock has decreased by 0.4% and is now trading at $77.68.
View which stocks have been most impacted by COVID-19.

Baxter International announced a quarterly dividend on Tuesday, February 16th. Shareholders of record on Friday, February 26th will be given a dividend of $0.245 per share on Thursday, April 1st. This represents a $0.98 dividend on an annualized basis and a yield of 1.26%. The ex-dividend date is Thursday, February 25th.
View Baxter International's dividend history.

Baxter International pays an annual dividend of $0.98 per share and currently has a dividend yield of 1.26%. Baxter International has been increasing its dividend for 5 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio of Baxter International is 29.61%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Baxter International will have a dividend payout ratio of 28.49% next year. This indicates that Baxter International will be able to sustain or increase its dividend.
View Baxter International's dividend history.

Baxter International issued an update on its FY21 earnings guidance on Thursday, February, 4th. The company provided earnings per share (EPS) guidance of $3.35-3.43 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.49. The company issued revenue guidance of +7-8% (implying $12.5-12.6 billion), compared to the consensus revenue estimate of $12.17 billion.

16 brokers have issued twelve-month target prices for Baxter International's stock. Their forecasts range from $80.00 to $105.00. On average, they expect Baxter International's share price to reach $92.27 in the next year. This suggests a possible upside of 18.8% from the stock's current price.
View analysts' price targets for Baxter International or view top-rated stocks among Wall Street analysts.

506 employees have rated Baxter International CEO José (Joe) Almeida on Glassdoor.com. José (Joe) Almeida has an approval rating of 85% among Baxter International's employees.

Some companies that are related to Baxter International include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Intuitive Surgical (ISRG), Becton, Dickinson and (BDX), Boston Scientific (BSX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), DexCom (DXCM), ResMed (RMD), Hologic (HOLX), Teleflex (TFX), Insulet (PODD), Varian Medical Systems (VAR) and STERIS (STE).
View all of BAX's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), Johnson & Johnson (JNJ), Pfizer (PFE), Cisco Systems (CSCO), Honeywell International (HON), Intel (INTC), Abbott Laboratories (ABT), The Procter & Gamble (PG), AT&T (T) and Verizon Communications (VZ).

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Baxter International's stock is owned by a variety of institutional and retail investors. Top institutional investors include Caisse DE Depot ET Placement DU Quebec (1.60%), Bank of New York Mellon Corp (0.87%), California Public Employees Retirement System (0.80%), New York State Common Retirement Fund (0.49%), UBS Asset Management Americas Inc. (0.48%) and Sumitomo Mitsui Trust Holdings Inc. (0.34%). Company insiders that own Baxter International stock include Albert P L Stroucken, Andrew Frye, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Sean Martin, Third Point Llc and Thomas T Stallkamp.
View institutional ownership trends for Baxter International.

BAX stock was sold by a variety of institutional investors in the last quarter, including Mawer Investment Management Ltd., Bessemer Group Inc., State of Tennessee Treasury Department, PGGM Investments, Sumitomo Mitsui Trust Holdings Inc., Handelsbanken Fonder AB, Prudential PLC, and Rhumbline Advisers. Company insiders that have sold Baxter International company stock in the last year include Albert P L Stroucken, Andrew Frye, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, and John D Forsyth.
View insider buying and selling activity for Baxter International or view top insider-selling stocks.

BAX stock was purchased by a variety of institutional investors in the last quarter, including New York State Common Retirement Fund, Caisse DE Depot ET Placement DU Quebec, Amundi Pioneer Asset Management Inc., UBS Asset Management Americas Inc., California Public Employees Retirement System, Bank of New York Mellon Corp, Strategic Blueprint LLC, and Toronto Dominion Bank.
View insider buying and selling activity for Baxter International or or view top insider-buying stocks.

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of BAX stock can currently be purchased for approximately $77.68.

Baxter International has a market capitalization of $39.24 billion and generates $11.36 billion in revenue each year. The medical instruments supplier earns $1.00 billion in net income (profit) each year or $3.31 on an earnings per share basis.

Baxter International employs 50,000 workers across the globe.

The following companies are subsidiares of Baxter International: ApaTech Limited, Baxter (China) Investment Co. Ltd, Baxter (Hellas) EPE, Baxter (India) Private Limited, Baxter AO, Baxter Belgium SPRL, Baxter Company Ltd, Baxter Corporation (Canada), Baxter Corporation Englewood, Baxter Deutschland GmbH, Baxter Distribution Center Europe SA, Baxter Healthcare (Guangzhou) Company Ltd, Baxter Healthcare (Shanghai) Company Ltd., Baxter Healthcare (Suzhou) Company Ltd, Baxter Healthcare (Thailand) Company Limited, Baxter Healthcare (Tianjin) Co. Ltd., Baxter Healthcare Corporation, Baxter Healthcare Limited, Baxter Healthcare Limited (Hong Kong China), Baxter Healthcare Limited (Taiwan), Baxter Healthcare Pty Ltd, Baxter Healthcare SA, Baxter Healthcare SA (Singapore Woodlands Branch), Baxter Healthcare Trading (Shanghai) Co. Ltd., Baxter Holding B.V., Baxter Hospitalar Ltda., Baxter Incorporated, Baxter Innovations & Business Solutions Private Limited (India), Baxter Limited, Baxter Manufacturing (Thailand) Co. Ltd., Baxter Medical AB, Baxter Oncology GmbH, Baxter Pharmaceutical Solutions LLC, Baxter Pharmaceuticals (Asia) Pte Ltd., Baxter Pharmaceuticals India Pvt Ltd., Baxter Polska Sp. z o.o., Baxter Productos Medicos Ltda., Baxter R and D Europe SPRL, Baxter S.A. de C.V., Baxter S.A.S., Baxter S.L., Baxter S.p.A., Baxter SA, Baxter Sales and Distribution LLC, Baxter Services Europe SA, Baxter Shared Services & Competencies Limited, Baxter de Guatemala Sociedad Anonima, Bieffe Medital S.p.A., Cheetah Medical, Cheetah Medical (Israel) Ltd., Cheetah Medical (UK) Limited, Cheetah Medical Inc., Gambro AB, Gambro Dasco S.p.A., Gambro Dialysatoren GmbH, Gambro Industries SAS, Gambro Lundia AB, Gambro Renal Products Inc., Laboratorios Baxter S.A., RTS Colombia SAS, Synovis Life Technologies Inc., and Synovis Micro Companies Alliance Inc..

Baxter International was founded in 1931.

The official website for Baxter International is www.baxter.com.

Baxter International is headquartered at One Baxter Parkway DF2-1W, Deerfield IL, 60015.

Baxter International's mailing address is One Baxter Parkway DF2-1W, Deerfield IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]